Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell differentiation from hematopoietic CD34+ progenitor cells.

A Curti1, M Fogli, M Ratta

  • 1L. and A. Seràgnoli, Institute of Hematology and Medical Oncology, University of Bologna, Italy.

Journal of Biological Regulators and Homeostatic Agents
|June 5, 2001
PubMed
Summary

Dendritic cells (DC), powerful antigen-presenting cells (APC), are crucial for initiating immune responses. Research focuses on their development from CD34+ progenitors for enhanced immunity and cancer vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study.

Hematological oncology·2025
Same author

Current smoking is related to severe damage in systemic lupus erythematosus patients.

Lupus·2024
Same author

A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure.

British journal of haematology·2023
Same author

Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report.

Radiology case reports·2018
Same author

Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors.

Gastroenterology research and practice·2017
Same author

Radiotherapy in the management of gist: state of the art and new potential scenarios.

Clinical sarcoma research·2017

Area of Science:

  • Immunology
  • Cell Biology
  • Vaccinology

Background:

  • Dendritic cells (DCs) are potent antigen-presenting cells (APCs) vital for initiating adaptive immune responses.
  • Their unique properties make them promising candidates for enhancing immunity against pathogens and in cancer vaccine development.

Purpose of the Study:

  • To summarize recent findings on myeloid dendritic cell (DC) differentiation from hematopoietic CD34+ progenitors.
  • To review methods for in vitro DC generation.
  • To highlight the clinical implications of understanding DC function.

Main Methods:

  • Review of recent scientific literature on dendritic cell differentiation and generation.
  • Analysis of methods for generating myeloid DCs from CD34+ hematopoietic stem cells.

Related Experiment Videos

  • Synthesis of data on DC function and clinical applications.

    • Main Results:

    • Recent advancements in understanding the differentiation pathways of myeloid DCs from CD34+ progenitors.
    • Established protocols for in vitro generation of functional DCs.
    • Growing evidence supports the potential of DCs in immunotherapy.

    Conclusions:

    • Understanding DC differentiation and generation is key to harnessing their therapeutic potential.
    • In vitro generated DCs hold significant promise for clinical applications in infectious disease and cancer immunotherapy.
    • Further research into DC biology will advance their use in vaccine strategies and immune modulation.